| Dr Bogdan Silviu Eftimie, MD | |
|
3200 Kearney Street, Fremont, CA 94538-2299 | |
| (510) 490-1222 | |
| Not Available |
| Full Name | Dr Bogdan Silviu Eftimie |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 24 Years |
| Location | 3200 Kearney Street, Fremont, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740458900 | NPI | - | NPPES |
| A77323 | Other | CA | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A77323 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Washington Hospital | Fremont, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ucsf Medical Group Business Services | 3779497870 | 1064 |
News Archive
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
A new study suggests that following a plant-based diet does not necessarily reduce the risk of cardiovascular disease.
Australian cricket great, Brett Lee, was today announced as Cochlear's first Global Hearing Ambassador. As one of the world's fastest bowlers, who has smashed multiple cricket records, Brett's new target is 360 million people - and raising awareness about hearing loss.
Knowledge about paediatric calcium and bone disorders has increased rapidly over the past twenty years. Great advances have been made in the underlying genetic basis for many conditions, in bone density and geometry imaging and in the development of new treatment options, calling for a new edition of 'Calcium and Bone Disorders in Children and Adolescents' which was first published in 2009.
› Verified 8 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881763597 PECOS PAC ID: 4284547274 Enrollment ID: O20031106000389 |
News Archive
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
A new study suggests that following a plant-based diet does not necessarily reduce the risk of cardiovascular disease.
Australian cricket great, Brett Lee, was today announced as Cochlear's first Global Hearing Ambassador. As one of the world's fastest bowlers, who has smashed multiple cricket records, Brett's new target is 360 million people - and raising awareness about hearing loss.
Knowledge about paediatric calcium and bone disorders has increased rapidly over the past twenty years. Great advances have been made in the underlying genetic basis for many conditions, in bone density and geometry imaging and in the development of new treatment options, calling for a new edition of 'Calcium and Bone Disorders in Children and Adolescents' which was first published in 2009.
› Verified 8 days ago
| Entity Name | University Of California San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
A new study suggests that following a plant-based diet does not necessarily reduce the risk of cardiovascular disease.
Australian cricket great, Brett Lee, was today announced as Cochlear's first Global Hearing Ambassador. As one of the world's fastest bowlers, who has smashed multiple cricket records, Brett's new target is 360 million people - and raising awareness about hearing loss.
Knowledge about paediatric calcium and bone disorders has increased rapidly over the past twenty years. Great advances have been made in the underlying genetic basis for many conditions, in bone density and geometry imaging and in the development of new treatment options, calling for a new edition of 'Calcium and Bone Disorders in Children and Adolescents' which was first published in 2009.
› Verified 8 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
A new study suggests that following a plant-based diet does not necessarily reduce the risk of cardiovascular disease.
Australian cricket great, Brett Lee, was today announced as Cochlear's first Global Hearing Ambassador. As one of the world's fastest bowlers, who has smashed multiple cricket records, Brett's new target is 360 million people - and raising awareness about hearing loss.
Knowledge about paediatric calcium and bone disorders has increased rapidly over the past twenty years. Great advances have been made in the underlying genetic basis for many conditions, in bone density and geometry imaging and in the development of new treatment options, calling for a new edition of 'Calcium and Bone Disorders in Children and Adolescents' which was first published in 2009.
› Verified 8 days ago
| Entity Name | Monterey Bay Oncology A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972542959 PECOS PAC ID: 6507826856 Enrollment ID: O20041012001045 |
News Archive
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
A new study suggests that following a plant-based diet does not necessarily reduce the risk of cardiovascular disease.
Australian cricket great, Brett Lee, was today announced as Cochlear's first Global Hearing Ambassador. As one of the world's fastest bowlers, who has smashed multiple cricket records, Brett's new target is 360 million people - and raising awareness about hearing loss.
Knowledge about paediatric calcium and bone disorders has increased rapidly over the past twenty years. Great advances have been made in the underlying genetic basis for many conditions, in bone density and geometry imaging and in the development of new treatment options, calling for a new edition of 'Calcium and Bone Disorders in Children and Adolescents' which was first published in 2009.
› Verified 8 days ago
| Entity Name | Emergency And Acute Care Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437103942 PECOS PAC ID: 9537108279 Enrollment ID: O20050502000734 |
News Archive
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
A new study suggests that following a plant-based diet does not necessarily reduce the risk of cardiovascular disease.
Australian cricket great, Brett Lee, was today announced as Cochlear's first Global Hearing Ambassador. As one of the world's fastest bowlers, who has smashed multiple cricket records, Brett's new target is 360 million people - and raising awareness about hearing loss.
Knowledge about paediatric calcium and bone disorders has increased rapidly over the past twenty years. Great advances have been made in the underlying genetic basis for many conditions, in bone density and geometry imaging and in the development of new treatment options, calling for a new edition of 'Calcium and Bone Disorders in Children and Adolescents' which was first published in 2009.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bogdan Silviu Eftimie, MD 2350 W. El Camino Real, 2nd Floor, Mountain View, CA 94040-6203 Ph: () - | Dr Bogdan Silviu Eftimie, MD 3200 Kearney Street, Fremont, CA 94538-2299 Ph: (510) 490-1222 |
News Archive
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
A new study suggests that following a plant-based diet does not necessarily reduce the risk of cardiovascular disease.
Australian cricket great, Brett Lee, was today announced as Cochlear's first Global Hearing Ambassador. As one of the world's fastest bowlers, who has smashed multiple cricket records, Brett's new target is 360 million people - and raising awareness about hearing loss.
Knowledge about paediatric calcium and bone disorders has increased rapidly over the past twenty years. Great advances have been made in the underlying genetic basis for many conditions, in bone density and geometry imaging and in the development of new treatment options, calling for a new edition of 'Calcium and Bone Disorders in Children and Adolescents' which was first published in 2009.
› Verified 8 days ago
Dr. Lakshmi Srinivasan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3200 Kearney St, Fremont, CA 94538 Phone: 510-490-1222 | |
Srilata Raman, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-248-3623 | |
Hannelore Mohr, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Frederick G. Hom, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Dr. Michael Andre Lenoir, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3448 Mowry Ave, Fremont, CA 94538 Phone: 510-373-3000 Fax: 844-965-9795 | |
Julie Yue Zhou, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Soham P Jhaveri, Do, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3200 Kearney St, Fremont, CA 94538 Phone: 510-490-1222 |